Heritage Foods Q1: record revenue up 18% YoY but consolidated PAT slides 38% as milk costs bite
PAT -38.41% YoY · revenue +17.71% · margins compressing
₹1,338.09 Cr
+17.71% YoY
₹24.97 Cr
-38.41% YoY
1.86%
-1.7pp YoY
₹2.72
Heritage Foods delivered its highest-ever Q1 topline — consolidated revenue of ₹1,338.1 Cr, up 17.7% YoY (from ₹1,136.8 Cr) and 15.6% QoQ — but profitability was gutted: consolidated PAT fell 38.4% YoY to ₹24.97 Cr (from ₹40.55 Cr) and EPS dropped to ₹2.72 from ₹4.37. The sequential PAT uptick of ~4% is a seasonality artifact (Q1 is peak summer milk-sales season) and not the story; the year-on-year collapse is. Net profit margin compressed to 1.87% from 3.55% a year ago and 2.06% last quarter. Standalone tells the same story — PAT ₹24.77 Cr, down ~34% YoY — so the weakness is operational, not a consolidation quirk.
Q1 FY-2027 vs prior quarters
The squeeze sits squarely on the raw-material line: consolidated cost of materials consumed rose 26.7% YoY (₹807.3 Cr to ₹1,022.5 Cr), far outpacing 17.7% revenue growth, so higher milk volumes were sold into a rising procurement-cost environment. The core Dairy segment result fell to ₹37.6 Cr from ₹50.6 Cr despite higher segment revenue, and the Feed segment result dropped to ₹1.7 Cr from ₹6.6 Cr. This confirms — rather than contradicts — management's Q4 (May 2026) concall guidance, which explicitly warned that near-term procurement cost pressure would persist despite improving milk availability; the print validates that cautious framing but leaves the long-term ~9% EBITDA-margin ambition looking distant at this run-rate. No quarter-specific street consensus was published (the sell-side FY27 view is annual: ~₹4,950 Cr revenue, ~₹20.55 EPS), so a beat/miss verdict against Q1 estimates isn't available.
The stock went into the print at ₹337, up 2.3% over the past month of trading.
For context: revenue is at a 6-quarter high.
Management projects cautious optimism for FY27, anticipating that near-term procurement cost pressures will persist despite improving milk availability. The core strategy remains focused on driving premiumization, with a goal to increase the revenue contribution from value-added products by 2-2.5% annually. The long-te
— This quarter: met
Alongside results the board approved two bolt-on consolidations that fit the stated premiumization/value-added push: raising its stake in Peanutbutter & Jelly Ltd (GETAWAY healthy-desserts brand, FY26 turnover ₹33.65 Cr) from 51% to 71% for ₹7.20 Cr cash, and buying the residual 5.60% of Heritage Novandie Foods (Livo yogurt) to take it to a wholly owned subsidiary. Both are small relative to the ₹1,338 Cr quarterly base and won't move near-term margins, but they extend the value-added-dairy strategy management is leaning on to lift mix over time.
What to watch
W1
Milk procurement cost trajectory into Q2 FY27 — COGS rose 26.7% YoY vs 17.7% revenue; margin recovery depends on this easing
W2
EBITDA/NPM path toward management's long-term ~9% EBITDA-margin goal — NPM this quarter was just 1.87% vs 3.55% YoY
W3
Value-added mix contribution (guided +2–2.5%/yr) as PBJL rises to 71% and HNFL to 100%; plus ₹200 Cr FY27 capex execution
Source in ₹ millions; converted to ₹ Cr (÷10). No exceptional items this quarter or in year-ago Q1, so raw YoY = adjusted YoY (the ₹7.79mn GST-refund exceptional was Q4/FY26 only). Consolidated PAT ₹24.97cr is total incl. ₹0.25cr NCI loss; owners' share ₹25.22cr. Both statements present; consolidated adds Feed segment + associate. Digital PDF, headers unambiguous, arithmetic ties.
Record revenue, profit collapse: margin crisis obscures growth
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Revenue guidance met (+17.7% vs implied 15%+). Margin guidance vague; prior 'cautious optimism' confirmed but profitability miss material. Capex raised ₹200→₹250 Cr, signaling scope increase mid-year.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Revenue growth of 17.7% masks a structural profitability crisis: PAT fell 38.4% YoY to ₹25 Cr on OPM compression to 4.6% (from 5.8%), driven by 7% milk inflation and flat volumes. Management frames this as a 'trough' in an inflationary cycle, but acknowledges liquid milk volume stagnation as 'the main problem' with no clear fix. VAP growth at 40% is solid, but dependency on pricing actions (which trigger volume loss) and weak liquid milk base raises sustainability concerns.
₹1338.1 Cr
Revenue · +17.7% YoY₹25 Cr
Reported PAT · +-38.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Delivered highest quarterly revenue in company history
MET₹1338.1 Cr; 17.7% YoY growth (not 18% as stated)
Healthy growth and disciplined execution despite challenges
OVERSTATEDRevenue +17.7% but PAT -38.4%; OPM 4.6% vs 5.8% prior year
VAP revenues growing 40% YoY with 35% volume, 5% price contribution
METVAP to ₹5,636 Cr; breakdown supported by category metrics (paneer +33%, curd +26%, ice cream +25%)
Milk procurement up 2% YoY to 18.10 lakh liters/day
METGrowth described as flat-to-negative for past 4 quarters; Q1 at 18.1 lakh liters but year-on-year modest
Liquid milk volume stable, prices up 4% YoY to ₹58.68/liter
MISSVolume admittedly flat; pricing action in March-April caused volume loss, partially clawed back by distribution
Milk EBITDA margin 3.03%, VAP EBITDA margin 8.06%
METMilk EBITDA 5.8% in Q1 FY26 → 3.03% in Q1 FY27; 275bp compression. VAP 9.7% → 8.06%; 164bp compression
Mini-flush in April-May will ease procurement prices; procurement prices stable or increase Q2
MISSMini-flush did not materialize; management now expects prices stable-to-firm Q2, expects October buffalo flush
Earnings quality
What changed since the last call
Capex guidance raised
UpgradeFY27 capex raised ₹200 Cr → ₹250 Cr (paneer, ghee, procurement infra). Signals accelerated growth platform investment despite current margin pressure.
Procurement price outlook darkened
DowngradePrior guidance: 'pressures will persist despite improving availability.' Actual: mini-flush failed, prices up 7% YoY, now expect stable-to-firm Q2, uncertain October recovery. 3.5-4% baseline inflation ongoing.
Margin profile downgraded
DowngradeOPM 4.6% (vs prior 5.8% Q1 FY26). Milk EBITDA 3.03% (vs 5.8%); 275bp compression. Management now frames as 'trough' phase requiring price normalization, not near-term recovery.
VAP contribution outperformed expectations
UpgradeVAP mix jumped to 44% from 36% YoY, exceeding 2-2.5% annual guidance. Driven by 40% volume+price growth and flat milk base, not necessarily sustainable at same pace.
Liquid milk volume issue escalated
NewManagement now explicitly: 'main problem we need to solve.' Four quarters of flat-to-negative growth. Pricing actions (5% VAP) in Q1 caused volume loss in March-April, only partially recovered.
The Q&A
Analysts pressed hard on three themes: (1) milk volume stagnation vs VAP expansion inconsistency—is procurement the constraint?; (2) gross margin decline despite VAP mix improvement; (3) liquid milk volume breakdown. Management held firm on long-term strategy but conceded milk volume is a 'main problem' and acknowledged 'trough' phase. No near-term fixes articulated; response leaned on 'cyclical' narrative and distribution expansion (1 lakh liters/day added in Q1, more planned).
Milk procurement pricing — Sameer Gupta, IIFL Capital
PartialMini-flush didn't materialize due to weather. Prices now stable/slight uptick expected Q2. October flush normal, but all bets dependent on rainfall. Expanding farmer network (adding 5,000 farmers Q1, 5,000 Q2) to secure volumes at right price.
VAP volume growth drivers — Abhishek Mathur, Systematix
Answered80% distribution expansion (new points in existing geographies), 20% market share gain from organized competitors (measured in paneer, curd, buttermilk). No new geographies opened. Cycling low base from Q1 FY26 rain impact.
Gross margin decline — Pratik Kothari, Unique PMS
AnsweredCow milk mix shift (buffalo down 20% due to scarcity); cow milk +₹1/liter. SMP consumption higher at elevated cost (50bp impact). Packing material inflation (30bp). Mix change + inflation offset pricing and VAP gains.
Breakeven in loss-making regions/products — Pratik Kothari, Unique PMS
PartialGhee improved -12% → -8.5%, a 350bp gain. Losses in expansion regions reduced despite company profitability decline. If those regions had declined in line with overall margin, ₹1 Cr more loss. Trajectory right but no timeline to breakeven given.
Liquid milk volume stagnation — Pratik Kothari, Unique PMS
PartialCEOMD admits 'the main problem we need to solve.' COO: distribution network expansion (fresh distributors, Heritage happiness points), added 1 lakh liters/day Q1, focusing on throughput per point. Month-on-month growth visible March→April→May→June→July. Work in progress, highest priority.
VAP guidance sustainability — Abhishek Mathur, Systematix
PartialLong-term target: mid-to-high teens (16-17%) overall growth, milk 7-8%, VAP 25%. This quarter cycled low base (Q1 FY26 rain). One should expect smoothed performance over long period, not extrapolate quarterly spikes.
Price elasticity and volume recovery — Vignesh Iyer, Sequent Investments
AnsweredPricing actions ongoing every week across markets. Will continue if procurement prices stay firm (expected through Q2). Passing on raw material increases to consumer; no other way. Taking balanced view quarterly.
EBITDA margin recovery path — Nishita Shanklesha, Sapphire Capital
PartialRaw materials 75% of revenue, still significant. Not yet at stage where VAP EBITDA grows despite milk inflation. Working toward premium positioning to price irrespective of raw cost. Target high single-digit EBITDA (7%+). Median prior years 7-7.5%; should aim for that, not 6%. Raw milk normalization will be primary driver.
Normalized margin sustainability — Viraj Mehta, Enigma Investment
PartialAt trough now due to inflation. Long-term milk cost trend 3.5-4% YoY baseline. Intent is to grow VAP net revenue ahead of 3.5-4% milk inflation so EBITDA accretive. If business can procure even in inflation, grow when opportunity comes, expand VAP 3-4% annually, it's strong and will ride cycles. Margins expand widely when milk prices fall; that's not normal.
Capex and new projects — Nishita Shanklesha, Sapphire Capital
AnsweredPaneer project and ghee project under execution, plus raw milk procurement, minor capex. Total ~₹250 crores for year.
Guidance
Mid-to-high teen growth (16-17%) targeted long-term; milk 7-8%, VAP 25%
MediumLong-term trajectory. Milk growth constrained by volume ceiling (flat past 4 qtrs); VAP mix expansion to offset. Q1 VAP 40% benefited from low base (Q1 FY26 rain impact) and flat milk volumes.
Long-term EBITDA target: high single-digits (7%+); median prior yrs 7-7.5%
LowCurrently 4.6% OPM. No timeline. Dependent on: (a) raw milk costs normalizing (cyclical, 3.5-4% baseline inflation), (b) VAP mix to 50% by FY30, (c) resolving flat milk volume issue.
FY27 capex ₹250 Cr (vs prior ₹200 Cr guidance)
HighTwo projects: paneer and ghee; also raw milk procurement, minor capex. Increase signals accelerated timeline or scope expansion mid-year.
Risks the call surfaced
Milk volume stagnation
HighLiquid milk volumes flat past 4 quarters despite pricing actions. Pricing (5% VAP) triggers volume loss; distribution expansion claw-back incomplete. Overhead absorption impaired; profit leverage lost even with VAP growth.
Procurement cost inflation
HighMilk procurement +7% YoY to ₹46.61/liter. Mini-flush in April-May did not materialize; prices remain firm. Baseline inflation 3.5-4% YoY structural. Buffalo flush (Oct-Nov) uncertain due to El Niño and potential unseasonal rains affecting yield/fodder.
Gross margin compression drivers
MediumGross margin down ~250bp vs Q4 FY26 due to: (a) cow milk mix shift (buffalo down 20%, cow +₹1/liter), (b) SMP consumption higher at elevated cost (~50bp), (c) packing material inflation (~30bp). VAP mix improvement and pricing (5%) insufficient to offset.
VAP growth sustainability
MediumQ1 VAP growth 40% benefited from low Q1 FY26 base (rain impact). Management guided long-term 25% VAP growth; Q1 50%+ expansion due to flat milk volumes inflating VAP %. Sustaining high growth requires milk volumes to recover (conflict with other assumptions) or market share gains in organized channels (mature markets risk).
Execution risk on new geographies and products
MediumGhee EBITDA -8.5% (improving from -12% but still loss-making). Consumer packs and Mumbai/North expansion flagged as requiring breakeven timeline before contribution. Get-A-Way near-breakeven but still infant-stage. Heritage Novandie (Livo) newly consolidated. Cumulatively, loss-making portfolio absorbs margin uplift.
Management
Score 6/10. Candid on problems (liquid milk volume stagnation is 'main problem'), margin compression drivers clearly articulated. But long-term guidance vague ('high single-digit EBITDA,' no timeline). Deflected some specificity with 'cyclical business' narrative rather than committed targets. Mixed. Revenue growth +17.7% solid; VAP scaling impressive (+40%). But PAT -38.4% is a miss on profitability despite top-line momentum. Milk volumes flat past 4 quarters signals execution constraint. Distribution expansion ongoing (1 lakh liters/day) but claw-back incomplete.
1 · Oct-Nov 2026
Buffalo flush onset; procurement price trajectory critical for FY27 margin floor
2 · Q2 FY27
Liquid milk volume recovery via distribution expansion; throughput per point increasing month-on-month
3 · FY27 (full year)
Paneer and ghee capex ramp; two loss-making assets targeting breakeven within 4-6 qtrs
VAP growth at 40% is solid, but dependency on pricing actions (which trigger volume loss) and weak liquid milk base raises sustainability concerns.